ENGENE HOLDINGS INC(ENGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ENGN ENGENE HOLDINGS INC

Closed 07-15 16:00:00 EDT

1.90

+0.01

+0.26%

盘后1.89

-0.01-0.53%

16:10 EDT

High1.96	Low1.83	Vol813.16K
Open1.88	D1 Closing1.90	Amplitude7.12%
Mkt Cap127.27M	Tradable Cap42.72M	Total Shares66.98M
T/O1.55M	T/O Rate3.62%	Tradable Shares22.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":1.9,"timestamp":1784145600000,"preClose":1.895,"halted":0,"volume":813162,"hourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.9,"latestTime":"16:10 EDT","volume":4450,"amount":8410.56,"timestamp":1784146204544,"change":-0.01,"changeRate":-0.005263,"amplitude":0},"delay":0,"changeRate":0.0026385224274405768,"floatShares":22486700,"shares":66984661,"eps":-2.122895,"marketStatus":"Closed","change":0.005,"latestTime":"07-15 16:00:00 EDT","open":1.88,"high":1.96,"low":1.825,"amount":1551935,"amplitude":0.07124,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.122895,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784188800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":1.895,"preHourTrading":{"tag":"盘前","latestPrice":1.8998,"preClose":1.895,"latestTime":"07:45 EDT","volume":17,"amount":32.2966,"timestamp":1784115946012,"change":0.0048,"changeRate":0.002533,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.89,"preClose":1.9,"latestTime":"16:10 EDT","volume":4450,"amount":8410.56,"timestamp":1784146204544,"change":-0.01,"changeRate":-0.005263,"amplitude":0},"volumeRatio":0.637453,"impliedVol":1.4069,"impliedVolPercentile":0.6571},"requestUrl":"/m/hq/s/ENGN","defaultTab":"news","newsList":[{"id":"2651465927","title":"Rectify Pharmaceuticals Announces Appointment of Constantine Chinoporos as Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465927","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651465927?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:00","pubTimestamp":1784120407,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUA4ZJ7X0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN","GERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644036936","title":"enGene amends filing, lifts estimated non-cash stock-comp restructuring charge to $4.7 million-$5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2644036936","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644036936?lang=en_us&edition=fundamental","pubTime":"2026-06-19 04:07","pubTimestamp":1781813232,"startTime":"0","endTime":"0","summary":"enGene filed an amended 8-K to update restructuring charges tied to its June 14 plan to cut about 50% of its workforce.Added performance-based equity retention awards, lifting expected non-cash stock-based compensation tied to the restructuring to USD 4.7 million-USD 5 million.Projected restructuring cash costs unchanged at USD 5.7 million-USD 6.4 million, mainly severance and benefits; most charges still expected in 2H 2026.Estimated retention costs now include up to USD 1.7 million cash, up to USD 2.8 million non-cash compensation linked to milestone-based vesting.CEO Ronald Cooper received a 400,000-share performance-based option at USD 1.75, vesting on BLA acceptance by Sep. 30, 2027 and FDA approval by Dec. 31, 2028.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL6Fvl96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644033202","title":"EnGene Shares Fall After Morgan Stanley Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2644033202","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644033202?lang=en_us&edition=fundamental","pubTime":"2026-06-19 03:10","pubTimestamp":1781809808,"startTime":"0","endTime":"0","summary":"EnGene (ENGN) shares fell 1.4% in Thursday trading after Morgan Stanley downgraded the stock to underweight from equalweight.Trading volume stood at over 735,000 shares compared with a daily average of nearly 1.6 million.Price: 1.72, Change: -0.02, Percent Change: -1.44","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644125085","title":"enGene Detalimogene's Durability Profile 'Not Competitive,' Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2644125085","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644125085?lang=en_us&edition=fundamental","pubTime":"2026-06-18 20:45","pubTimestamp":1781786706,"startTime":"0","endTime":"0","summary":"enGene (ENGN) is experiencing \"reduced confidence\" from physicians that the company's LEGEND clinical trial to treat patients with non-muscle invasive bladder cancer would support significant adoption","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644026337","title":"Morgan Stanley Downgrades enGene to Underweight From Equalweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2644026337","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644026337?lang=en_us&edition=fundamental","pubTime":"2026-06-18 18:18","pubTimestamp":1781777937,"startTime":"0","endTime":"0","summary":"enGene Holdings (ENGN) has an average rating of hold and mean price target of $6.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643756302","title":"enGene Holdings Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2643756302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643756302?lang=en_us&edition=fundamental","pubTime":"2026-06-16 18:29","pubTimestamp":1781605740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 06:29 ET (10:29 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206023","title":"Engene Reports Second Quarter 2026 Financial Results And Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206023","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206023?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:28","pubTimestamp":1781530136,"startTime":"0","endTime":"0","summary":"June 15 (Reuters) - enGene Therapeutics Inc ::*ENGENE REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE*ENGENE THERAPEUTICS - IMPLEMENTS WORKFORCE REDUCTION OF ABOUT 50% IN JU","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nRSD7wj98j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643820617","title":"enGene Therapeutics - Estimates $5.7-$6.4 Mln Restructuring Costs and $4.7-$5 Mln Non-Cash Stock Compensation - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643820617","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643820617?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:17","pubTimestamp":1781529459,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nFWN42N02H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206564","title":"enGene Holdings Q2 EPS $(0.43) Beats $(0.47) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206564","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206564?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:06","pubTimestamp":1781528784,"startTime":"0","endTime":"0","summary":"enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.47) by 8.51 percent. This is a 15.69 percent increase over losses of $(0.51) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/53192968/engene-holdings-q2-eps-0-43-beats-0-47-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206825","title":"enGene Q2 FY26 net loss widens to USD 30.23 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206825","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206825?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:01","pubTimestamp":1781528513,"startTime":"0","endTime":"0","summary":"enGene posted a net loss attributable to common shareholders of USD 30.2 million, or USD 0.43 per share, for Q2 ended April 30.Total operating expenses rose to USD 32 million from USD 27.1 million a year earlier; R&D climbed to USD 22.2 million.Cash, cash equivalents and marketable securities totaled USD 285.2 million as of April 30.LEGEND Cohort 1 interim data showed a 54% complete response rate at any time; FDA BLA discussions planned for 2H 2026.Workforce cut by about 50% to preserve cash; CFO Ryan Daws, CLO Lee Giguere, CSOO Alex Nichols to depart July 15.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on June 15, 2026, and i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDLChb7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643367206","title":"enGene Therapeutics Inc:  CFO Ryan Daws to Depart From Co, Effective July 15, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643367206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643367206?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:00","pubTimestamp":1781528404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUACD6GQJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643206845","title":"enGene Therapeutics - Implements Workforce Reduction of About 50% in June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643206845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643206845?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:00","pubTimestamp":1781528404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUACD6GQJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205046","title":"enGene Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205046?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:00","pubTimestamp":1781528404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUACD6GQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642264329","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264329","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642264329?lang=en_us&edition=fundamental","pubTime":"2026-06-12 18:00","pubTimestamp":1781258400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Dave & Buster's                                 1Q       .60   4:05 PM. ·Accenture Plc Class A                            3Q      3.72       BMO","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4585","LU0323240290.USD","LU0553294199.USD","LU1003077747.HKD","LZB","DOMO","BK4113","LU1814569148.SGD","LU1823568750.SGD","SGXZ31699556.SGD","LU1228905540.USD","BK4216","SG9999018865.SGD","JBL","LU0302445910.USD","IE00BJJMRY28.SGD","CGC","LU0545039389.USD","BK4566","IE00BHPRN162.USD","LU0130517989.USD","LU1506573853.SGD","BK4581","BK4145","BK4534","PLAY","LU0323239441.USD","BK4557","LU1032466523.USD","SG9999004303.SGD","BK4532","LU0868494708.USD","LU1169590202.USD","BK4559","LU0342679015.USD","BK4561","AIOT","IE00BFSS7M15.SGD","IE00BJJMRX11.SGD","KMX","KR","BK4504","ENGN","SG9999017495.SGD","ACN","LU1861220033.SGD","HITI","BK4533","LU1366333091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642475423","title":"enGene Therapeutics held annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642475423","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642475423?lang=en_us&edition=fundamental","pubTime":"2026-06-11 04:10","pubTimestamp":1781122250,"startTime":"0","endTime":"0","summary":"enGene Therapeutics held its annual general meeting on June 9, 2026.Shareholders backed the board’s slate of director nominees.Shareholders ratified the appointment of the company’s auditor, with authority granted to set the auditor’s remuneration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL2gvkWY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642447338","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2642447338","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642447338?lang=en_us&edition=fundamental","pubTime":"2026-06-10 18:00","pubTimestamp":1781085600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Stitch Fix Inc.                                 3Q      (.06)  4:05 PM. ·Dave & Buster's                                 1Q       .60   4:05 PM. ·Domo Inc. Class B                               1Q      (.04)      AMC","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565833.HKD","LU0342679015.USD","LU0792757196.USD","LU0210536198.USD","LU0070302665.USD","LU0957808578.USD","LU0130102774.USD","LU1934455277.USD","LU0965509283.SGD","BK4209","LU0965509101.SGD","LU0198837287.USD","LU1429558221.USD","LU0081259029.USD","LZB","LU2357305700.SGD","LU0234570918.USD","LU2860962120.EUR","BK4216","LU1366192091.USD","LU0545039389.USD","LU2108987350.USD","LU2896262040.SGD","BK4568","BK4527","BK4551","LU0738911758.USD","LU0323591593.USD","BK4548","IE00BLSP4452.SGD","IE00BQXX3C00.GBP","LU1941712264.USD","LU2095319765.USD","LU2746668974.SGD","BK4504","ACB","LU2125154935.USD","BK4139","LU1003077747.HKD","LU1934455863.HKD","LU0082616367.USD","LU0289960550.SGD","LU0417517546.SGD","BK4095","IE00BMPRXR70.SGD","LU2236285917.USD","LU1642822529.SGD","ADBE","LU2087625088.SGD","LU0345774631.USD","LU2458330169.SGD","LU0708995401.HKD","LU0949170772.SGD","LU1941712348.USD","LU1989764664.SGD","LU0158827948.USD","LU2543165471.USD","BK4588","LU1989772840.SGD","LU0109392836.USD","LU0878866978.SGD","SGXZ99366536.SGD","LU1815333072.USD","LU2210150020.SGD","LU2089284900.SGD","BK4088","LU0256863811.USD","LU0444973449.USD","LU1778281490.HKD","SG9999001424.SGD","BK4581","IE00B7SZLL34.SGD","LU1934455194.USD","IE00B5949003.HKD","IE00BYQQ9H92.USD","BK4178","LU0348723411.USD","LU1035773651.USD","LU1623119135.USD","IE0004445239.USD","PLAY","BK4097","LU1633808545.USD","LU0057025933.USD","IE00BN8TJ469.HKD","LU0672654240.SGD","LU2125154778.USD","LU0320765059.SGD","LU2360032135.SGD","IE00B775SV38.USD","LU1169590202.USD","BK4547","LU0175139822.USD","LU0106261372.USD","ORCS","LU0472753341.HKD","LU1935043023.USD","BK4007","LU2054465674.USD","BK4516","LU1803068979.SGD","LU0068578508.USD","LU2458330243.SGD","SFIX","LU0661504455.SGD","BK4200","BK4583","LU0314106906.USD","LU1267930813.SGD","LU0965509010.AUD","HITI","LU0942090050.USD","IE00B19Z9505.USD","SG9999003800.SGD","LU2250418816.HKD","LU0719512351.SGD","BK4528","LU1201861249.SGD","ENGN","LU1037948541.HKD","IE0009356076.USD","IE00BQXX3D17.EUR","LU1720051108.HKD","LU2746668461.USD","LU0868494708.USD","LU0289961442.SGD","IE0002270589.USD","BK4157","LU1037948897.HKD","LU1935042488.USD","NAVN","LEN","LU2237957902.USD","BK4122","LU1852331112.SGD","IE00BQXX3F31.USD","BK4023","LU0957791311.USD","LU0648001328.SGD","LU1815336760.USD","LU0157215616.USD","BK4534","CGC","LU2089283258.USD","IE00BBT3K403.USD","BK4533","LU0069063385.USD","LU0980610538.SGD","BK4142","IE00BMPRXN33.USD","LU1823568750.SGD","BK4566","BK4592","BK4094","LU0985489474.SGD","LU0170899867.USD","LU1489326972.SGD","IE00BFXG0V08.USD","LU1989764748.USD","LU2317271919.USD","LU0234572021.USD","LU1674673428.USD","OXM","IE00B19Z3581.USD","BK4082","LU2210149790.SGD","LU1267930730.SGD","LU0433182093.SGD","LU1069347547.HKD","JILL","LU1674673691.USD","LU2360106780.USD","LU0965508806.USD","LU2237438978.USD","SG9999011175.SGD","LU2237957811.SGD","LU1691799644.USD","IE00BMPRXQ63.HKD","BK4596","LU2023251221.USD","LU0353189763.USD","BK4585","LU1119994496.HKD","BK4554","LU0511384066.AUD","LU1712237335.SGD","IE00BLSP4239.USD","ORCL","ORCU","LU0553294199.USD","LU0006306889.USD","LU1046421795.USD","AEMD","LU1548497426.USD","LU0476273544.USD","LU1261432733.SGD","LU1935042991.SGD","ORCX","RH","BK4567","CHWY","LU1084165304.USD","LU1989772923.USD","SGXZ81514606.USD","LU0289739343.SGD","LU0109391861.USD","LU1366333091.USD","LU1435385759.SGD","MH","LU1720051017.SGD","IE00B5TLWC47.USD","LU1935042215.USD","ADBG","LU1935043536.SGD","LU1235294995.USD","LU0889566641.SGD","IE00B19Z3B42.SGD","MSOS","BK4543","LU0061474960.USD","SGXZ51526630.SGD","BK4559","LU0314104364.USD","LU0345774391.USD","SG9999000418.SGD","LU0444971666.USD","IE00B3S45H60.SGD","LU0868494617.USD","LU0208291251.USD","LU1169589451.USD","BK4202","LU0353189680.USD","BK4204","LU0861579265.USD","AIOT","BK4557","LOVE","LU2326559502.SGD","DOMO","LU0056508442.USD","LU0320765489.SGD","BK4538","LU1506573853.SGD","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483873","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483873","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483873?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:00","pubTimestamp":1780912800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·United Nat Foods                                3Q       .76   7:00 AM. ·Stitch Fix Inc.                                 3Q      (.06)  4:05 PM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","RH","SFIX","LU0057025933.USD","LU0208291251.USD","LU2237957811.SGD","LU1989764748.USD","BK4554","LU2458330169.SGD","LU0345774631.USD","LU1935042991.SGD","LU0175139822.USD","LU0198837287.USD","LU2108987350.USD","LU1037948897.HKD","LU0472753341.HKD","BK4567","LU0719512351.SGD","IE00BLSP4452.SGD","LU1201861249.SGD","LU0170899867.USD","LU0210536198.USD","GLOO","BK4533","LU0985489474.SGD","MH","LU0861579265.USD","BK4161","LU1712237335.SGD","IE00BQXX3C00.GBP","BK4088","IE0031619046.USD","BK4102","LU0965509101.SGD","LU2237957902.USD","BK4548","BK4209","LU1506573853.SGD","LU0006306889.USD","LU1941712348.USD","BK4547","IE00B19Z9505.USD","LU0957791311.USD","LU1642822529.SGD","BK4200","BK4202","BK4504","LMNR","LU2089284900.SGD","LU2357305700.SGD","LU2458330243.SGD","LU0314104364.USD","LU0068578508.USD","LU0109391861.USD","LU0444973449.USD","LU0082616367.USD","BK4551","BK4096","IE0002270589.USD","LU0417517546.SGD","BK4543","LU1934455194.USD","LEN","LU2125910179.SGD","AEMD","IE0004445239.USD","LU0106261372.USD","LU0289960550.SGD","LU2089279066.USD","LU2210150020.SGD","LU2125154778.USD","LU0661504455.SGD","IE00B775SV38.USD","LU1267930813.SGD","LU1852331112.SGD","LU0878866978.SGD","LU2023251221.USD","LU2236285917.USD","IE00B7SZLL34.SGD","SGXZ51526630.SGD","BK4094","BK4212","LU0130102774.USD","LU0476273544.USD","LU1778281490.HKD","BK4216","LU1261432733.SGD","LU1934455863.HKD","AVO","BK4538","IE00BN8TJ469.HKD","BK4539","CNM","LU0353189763.USD","LU0648001328.SGD","ADBG","LU0320765489.SGD","LU1989772840.SGD","SGXZ81514606.USD","SUJA","BK4592","LU1815336760.USD","BK4541","LU0792757196.USD","IE00BFXG0V08.USD","CBRL","LU0738911758.USD","LU1429558221.USD","LU1169589451.USD","LU0158827948.USD","IE00BMPRXR70.SGD","LU1169590202.USD","LU1934455277.USD","BK4139","LU1691799644.USD","OXM","LU1489326972.SGD","LU0056508442.USD","IE00B19Z4B17.USD","IE00BQXX3D17.EUR","LOVE","LU0965508806.USD","LU0348723411.USD","LU1037948541.HKD","BK4527","CASY","IE00B66KJ199.SGD","IE00BYQQ9H92.USD","LU0256863811.USD","BK4516","LU0289739343.SGD","LU1674673428.USD","SG9999001424.SGD","ENGN","SGXZ99366536.SGD","BK4142","IE00BMPRXN33.USD","MAMA","LU1003077747.HKD","LU0965509010.AUD","LU2360106780.USD","BK4189","LU1084165304.USD","LU0889566641.SGD","LU0433182093.SGD","LU1548497426.USD","BK4007","BK4113","IE0009356076.USD","LU0069063385.USD","FCEL","LU1046421795.USD","IE0009354923.USD","IE00B7SZL793.SGD","LU1435385759.SGD","ORCU","LU1923621640.USD","IE00BQXX3F31.USD","LU0081259029.USD","LU0545039389.USD","IE00B5949003.HKD","IE00BLSP4239.USD","LU0980610538.SGD","BK4566","BK4583","LU0889565833.HKD","LU0672654240.SGD","SG9999000418.SGD","BK4095","LU0353189680.USD","LU1267930730.SGD","LU0320765059.SGD","LU2360032135.SGD","LU0234570918.USD","TITN","LU0708995401.HKD","CHWY","LU0070302665.USD","LU0957808578.USD","LU0323591593.USD","BK4561","LU1235294995.USD","LE","BK4023","LU2125154935.USD","MSOS","LU2229751404.USD","ORCS","SJM","BK4082","IE00BBT3K403.USD","LU0553294199.USD","LU1674673691.USD","LU2746668974.SGD","BK4557","ORCL","LU2746668461.USD","BK4588","LU0234572021.USD","SG9999003800.SGD","LU0511384066.AUD","SAIL","LU1069347547.HKD","BK4204","BK4585","LU1989772923.USD","LU0314106906.USD","BK4528","LU0342679015.USD","LU0868494708.USD","LU2125910336.SGD","LU2210149790.SGD","LAKE","ADBE","BK4097","LU1720051017.SGD","LU1823568750.SGD","LU2087625088.SGD","LU2095319765.USD","LU1935043023.USD","ACB","MTN","LU1803068979.SGD","BK4596","LU0868494617.USD","IE00B5TLWC47.USD","LU2896262040.SGD","ASO","BK4178","LU1989764664.SGD","BK4559","LU1935042488.USD","LU1720051108.HKD","LU0109392836.USD","UNFI","DOMO","LU0444971666.USD","IE00B19Z3581.USD","LU1119994496.HKD","LU1623119135.USD","LU0557290698.USD","LU1941712264.USD","IE00B3S45H60.SGD","LU2054465674.USD","LU2317271919.USD","LU0965509283.SGD","BK4568","LU2326559502.SGD","LU0345774391.USD","ORCX","BK4534","LU0157215616.USD","LU1935043536.SGD","LU1366192091.USD","LU1035773651.USD","IE00BMPRXQ63.HKD","BK4581","LU0942090050.USD","LU2543165471.USD","BK4122","SG9999011175.SGD","LU2089283258.USD","BK4104","JILL","LU0061474960.USD","GHM","IE00B19Z3B42.SGD","LU2860962120.EUR","LU1815333072.USD","LU2237438978.USD","NAVN","LU0289961442.SGD","BARK","LU1935042215.USD","LU2250418816.HKD","LU0949170772.SGD","CPB","LU1633808545.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639231627","title":"enGene Therapeutics Inc  expected to post a loss of 47 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2639231627","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639231627?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:38","pubTimestamp":1780058287,"startTime":"0","endTime":"0","summary":"enGene Therapeutics Inc  expected to post a loss of47cents a share - Earnings Preview enGene Therapeutics Inc ENGN.OQ ENGN.O is expected to  show no change in quarterly revenue when it reports  result","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL8N42611O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635721973","title":"enGene Holdings Is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2635721973","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635721973?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:41","pubTimestamp":1778794860,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ENGN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 14, 2026 17:41 ET (21:41 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635749789","title":"enGene price target lowered to $2 from $9 at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2635749789","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635749789?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:24","pubTimestamp":1778772243,"startTime":"0","endTime":"0","summary":"UBS lowered the firm’s price target on enGene (ENGN) to $2 from $9 and keeps a Neutral rating on the shares. Published first on TheFly – the ultima...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/engene-price-target-lowered-to-2-from-9-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/engene-price-target-lowered-to-2-from-9-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU1829250122.USD","UBS","BK4585","BK4588","LU1863844749.USD","ENGN","BK4534","LU3187612489.SGD","LU1863844665.USD","BK4118","IE0034235071.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.engene.com","stockEarnings":[{"period":"1week","weight":-0.013},{"period":"1month","weight":0.1698},{"period":"3month","weight":-0.7558},{"period":"6month","weight":-0.7945},{"period":"1year","weight":-0.4326},{"period":"ytd","weight":-0.7901}],"compareEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0741},{"period":"6month","weight":0.0861},{"period":"1year","weight":0.2033},{"period":"ytd","weight":0.1025}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. Its lead product candidate is EG-70 (detalimogene voraplasmid), which is a non-viral immunotherapy to treat non-muscle invasive bladder cancer patients with carcinoma-in-situ (Cis), who are unresponsive to treatment with Bacillus Calmette-Guérin. The company was founded in 2023 and is based in Saint-Laurent, Canada.","exchange":"NASDAQ","name":"ENGENE HOLDINGS INC","nameEN":"ENGENE HOLDINGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ENGENE HOLDINGS INC(ENGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ENGENE HOLDINGS INC(ENGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ENGENE HOLDINGS INC,ENGN,ENGENE HOLDINGS INC股票,ENGENE HOLDINGS INC股票老虎,ENGENE HOLDINGS INC股票老虎国际,ENGENE HOLDINGS INC行情,ENGENE HOLDINGS INC股票行情,ENGENE HOLDINGS INC股价,ENGENE HOLDINGS INC股市,ENGENE HOLDINGS INC股票价格,ENGENE HOLDINGS INC股票交易,ENGENE HOLDINGS INC股票购买,ENGENE HOLDINGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ENGENE HOLDINGS INC(ENGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ENGENE HOLDINGS INC(ENGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}